Close Menu

NEW YORK (GenomeWeb) – Thermo Fisher Scientific said today that it has licensed its procalcitonin biomarker assay, BRAHMS PCT, to Siemens Healthineers.

Siemens' Atellica BRAHMS PCT assay received clearance from the US Food and Drug Administration on July 16, which the company announced in August.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.